Aug 31, 2017 - In a battle of sin stocks, we've got a draw. But each one's strength lies in a different area.
Aug 28, 2017 - There's a lot to like with Gilead's buyout of cell therapy leader Kite Pharma.
Sep 20, 2017 - If it seems like oncology drug prices are rapidly outpacing inflation, it’s because they are.
Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
Apr 18, 2017 - Ionis keeps doing what it's good at: developing new drugs and setting up future revenue streams
Sep 06, 2017 - Trivago surprised investors this week when it lowered its outlook for 2017. Here are the details.
Jul 15, 2017 - Forget the sky-high valuation. Vertex Pharmaceuticals stock is a smart pick.
Aug 26, 2017 - Pfizer and Amgen are encountering problems getting traction for their biosimilars. Is the system rigged against them?
Sep 05, 2017 - Optimism is soaring following the FDA approval of Novartis' CAR-T and the $11.9 billion acquisition of CAR-T developer Kite Pharma.
Nov 27, 2018 - Names on the move ahead of the open.